Asymmetric Outcomes of Type 1 Retinopathy of Prematurity after Bilateral Intravitreal Ranibizumab Treatment
Purpose. To present cases with retinopathy of prematurity (ROP), who were treated with intravitreal injection of ranibizumab (IVR) and had unpredictable asymmetric outcomes. Methods. A retrospective review was performed in infants with type 1 ROP and had bilateral IVR (0.25 mg/0.025 mL) as initial t...
Saved in:
| Main Authors: | Qiujing Huang, Qi Zhang, Yu Xu, Xunda Ji, Ping Fei, Jie Peng, Yi-an Li, Peiquan Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2017/1741386 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Ranibizumab in Patients with Treatment-Naïve Retinopathy of Prematurity
by: Hina Khalid, et al.
Published: (2025-08-01) -
Erratum: Bedside bilateral sequential intravitreal anti-VEGF injections for retinopathy of prematurity
Published: (2025-01-01) -
Refractive and Biometric Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age
by: Yen-Chih Chen, et al.
Published: (2018-01-01) -
Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report
by: Panagiotis G. Mitropoulos, et al.
Published: (2014-01-01) -
Successful Resolution of Preretinal Haemorrhage with Intravitreal Ranibizumab
by: Baharuddin Noorlaila, et al.
Published: (2016-01-01)